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SURGICAL MANAGEMENT 
OF COMPLETE 
ATRIOVENTRICULAR 
SEPTAL DEFECTS 
A twenty-year experience 
Creation of a competent left atrioventricular valve is a cornerstone in 
surgical repair of complete atrioventricular septal defects. To identify risk 
factors for mortality and failure of left atrioventricular valve repair and to 
determine the impact of cleft closure on postoperative atrioventricular 
valve function, we retrospectively analyzed hospital records of 203 patients 
between January 1974 and January 1995. Overall early mortality was 7.9%. 
Operative mortality decreased significantly over the period of the study 
from 19% (4/21) before 1980 to 3% (2/67) after 1990 (p = 0.03). Ten-year 
survival including operative mortality was 91.3% -+ 0.004% (95% confidence 
limit): all survivors are in New York Heart Association class I or II. 
Preoperative atrioventricular valve regurgitation was assessed in 203 
patients by angiography or echocardiography and was trivial or mild in 103 
(52%), moderate in 82 (41%), and severe in 18 (8%). Left atrioventricular 
valve cleft was closed in 93% (189/203) but left alone when valve leaflet 
tissue was inadequate and closure of the cleft might cause significant 
stenosis. Reoperation for severe postoperative l ft atrioventricular valve 
regurgitation was necessary in eight patients, five of whom initially did not 
have closure of the cleft and three of whom had cleft closure. Six patients 
had reoperation with annuloplasty and two patients required left atrioven- 
tricular valve replacement. Five patients survived reoperation and are 
currently in New York Heart Association class I or II. On most recent 
evaluation assessed by angiography or echocardiography (a mean of 59 
months after repair), left atrioventricular valve regurgitation was trivial or 
mild in 137 of the 146 survivors (94%) examined; none had moderate or 
severe left atrioventricular valve stenosis. By multiple logistic regression 
analysis, strong risk factors for early death and need for reoperation 
included postoperative pulmonary hypertensive crisis, immediate postop- 
erative severe left atrioventricular valve regurgitation, and double-orifice 
left atrioventricular valve. These results indicate that complete atrioven- 
tricular septal defects can be repaired with low mortality and good 
intermediate to long-term results. Routine approximation of the cleft is safe 
and has a low incidence of reoperation for left atrioventricular valve 
regurgitation. (J THORAC CARDIOVASC SURG 1995;110:1543-54) 
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R eports of surgical management of atrioventricu- lar (AV) septal defects over the past 20 years 
indicate a general trend of steady decline in peri- 
operative mortality. 1-3 However, left AV  valve re- 
gurgitation remains a critical hemodynamic compli- 
cation in patients surviving repair of AV  septal 
defects,I, 4, 5 and the creation of a competent left 
AV  valve is a cornerstone in successful surgical 
repair.2, 6 Accordingly, we reviewed the results of 
surgical correction of complete AV septal defects to 
identify risk factors for mortality and failure of left 
AV  valve repair and to determine the impact of cleft 
closure on postoperative AV valve function. 
Patients and methods 
Clinical data. This study includes the last 203 patients 
undergoing definitive repair of complete AV septal de- 
fects at our institution from January 1974 to January 1995 
and observed through March 31, 1995. All patients with 
forms of the AV septal defect in which no interventricular 
communication (or so small as to not require patch 
closure) was present by ventriculography or echocardiog- 
raphy were excluded from the study population. By using 
these criteria, we avoided a "transitional" AV septal 
defect subset. 
All patients in whom both palliative procedure and 
definite repair were performed at our institution were 
included in this population. Patients who received pallia- 
tion at other institutions and then were referred to our 
institution were excluded from the study population. 
Patients who received palliation in our institution but died 
before definite repair or had definite repair elsewhere 
were not included in this study (Appendix I). 
Patients with associated cardiovascular nd noncardio- 
vascular lesions were included with the following excep- 
tions. Those with complicated coexisting cardiac anoma- 
lies (i.e., transposition of great arteries, total anomalous 
pulmonary venous return) were excluded because the 
presence of these anomalies changes the basic physiology 
and natural history of the patient. Also patients with 
significantly unbalanced defects who required single- 
ventricle repair or bidirectional Glenn shunt associated 
with definitive repair of AV canal were excluded. 
Down's syndrome was present in 160 patients (78.8%). 
Ages ranged from 2 months to 204 months (median 14 
months) at the time of complete repair. There were 112 
girls and 91 boys. Weight at operation ranged from 2.4 to 
40.0 kg (mean 9.1 kg). Twelve patients (5.9%) were born 
prematurely (defined as <36-week gestational age and 
birth weight <2.5 kg). 
Ninety-one patients (44.8%) underwent palliative pul- 
monary artery banding before repair. The reasons for this 
included multiple ventricular septal defects (VSDs), asso- 
ciated preoperative noncardiac illness, significant ventric- 
ular imbalance, and preference of the referring cardiolo- 
gists. Two patients had aortic coarctation repair and one 
patient had patent ductus ligation before complete repair. 
Another two patients with combined tetralogy and com- 
plete AV septal defects had a Blalock-Taussig shunt 
before definitive repair. Since 1990, we have adopted an 
approach of early primary repair reserving pulmonary 
artery banding for neonates with complicated associated 
anomalies. 
Preoperative valuation. Patients routinely underwent 
preoperative cardiac catheterization. Echoeardiography 
also has been routinely performed since 1978. According 
to cardiac catheterization r echocardiography, preoper- 
ative left AV valve regurgitation was trivial or mild in 103 
patients (50.7%), moderate in 82 patients (40.4%), and 
severe in 18 patients (8.9%). Preoperative right AV valve 
regurgitation was trivial or mild in 187 patients (92.2%), 
moderate in 14 patients (6.9%), and severe in 2 patients 
(1.0%). 
Cardiac anomalies associated with complete AV septal 
defects are shown in Table I. A left-sided outflow tract 
obstructive lesion was present in 10 patients (4.9%). Six 
patients (3.0%) had double-orifice left AV valve, and 
single left-sided papillary muscle was present in 3 patients 
(1.5%). 
The AV valve structure was classified according to the 
Rastelli designation 7 with the exception of those cases in 
which there were two separate left AV valves. A total of 
129 valves were classified as type A (63.5%), 4 classified as 
type B (2.0%), and 68 classified as type C (33.5%). 
Operative management. Our operative management 
has evolved during our 20 years of experience. A median 
sternotomy is performed, adhesions if present are freed, 
and the external cardiac anatomy is assessed. Cannulation 
is accomplished by using the ascending aorta for arterial 
inflow and separate caval cannulas inserted through the 
right atrial appendage or superior vena cava, or both, for 
venous outflow to the pump. A small foam pad is inserted 
behind the heart o insulate the heart from the left phrenic 
nerve and the warmer mediastinal structures. Cardiopul- 
monary bypass is instituted at a flow rate of 2.4 L/min per 
square meter and the perfusate is cooled to 20 ° to 28 ° C. 
The left side of the heart is vented with a catheter inserted 
through the apex of the left ventricle and the aorta is 
crossclamped. Cold crystalloid cardioplegic solution is 
injected to a total volume of 15 ml/kg. Topical hypother- 
mia is added. The infusion of cardioplegic solution is 
repeated in 20 to 25 minutes, or sooner if electrical activity 
is noted. 
A careful assessment is made of the intracardiac anat- 
omy with particular reference to the AV valves. The 
chordal attachments o the margins of the left and right 
AV valve orifices are noted. Cold saline solution is 
inserted in the left ventricular vent to "float" the AV valve 
leaflets into apposition. The superior and inferior bridging 
valve tissue and their supporting chordal structures are 
not divided but left intact (Fig. 1, A). Interrupted hori- 
zontal mattress sutures of 6-0 polytetrafluoroethylene 
suture are placed in the left AV valve cleft, first at the base 
and then carried toward the free edge of the left AV valve 
orifice (Fig. 1, B). These sutures are left untied and the 
leaflets are retracted until the septal portion of the VSD 
patch is inserted. The VSD patch is constructed from soft 
knitted Dacron velour and fashioned in a half-moon 
shape. The VSD patch is sutured to the right side of the 
crest of the ventricular septum with 5-0 polypropylene 
suture beginning under the superior bridging leaflet and 
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carried inferiorly. A single over-and-over technique alter- 
nating with a horizontal mattress technique is used to 
avoid entrapment of any of the right AV valve chordal 
structures. 
Once the septal portion of the VSD patch is secured, 
the previously placed cleft sutures are tied. Drawing the 
cleft sutures together drapes the superior and inferior 
bridging leaflets over the upper margin of the VSD patch 
in a relaxed fashion. A separate 5-0 polypropylene suture 
secures the bridging leaflets to the upper margin of the 
VSD patc h (Fig. 1, C). The left ventricle is again filled 
through the left ventricular vent catheter to confirm 
complete closure of the VSD and good approximation of
the reconstructed left AV valve. 
A generous rectangle of fi'esh pericardium is then 
harvested and placed with the mesothelial surface toward 
the left AV valve orifice. A separate 5-0 polypropylene 
sutures is used to close the primum atrial septal defect 
(ASD) beginning at the cleft closure and running in both 
directions. Care should be taken that neither the VSD nor 
ASD patches places any tension on the left AV valve. 
Inferiorly the ASD suture line is carried off the inferior 
bridging leaflet onto the left AV valve anulus and under 
the coronary sinus until the atrial septal tissue is encoun- 
tered (Fig i 1, D). The pericardium is then trimmed until it 
fits into the remainder of the ASD in a relaxed fashion. 
Fig. 1, E shows the completed repair before the right 
atrium is Closed. 
In the early 88 patients in our series, a single Dacron 
patch technique was used for repair. 8 In the recent 115 
(57%) patients, the two-patch repair technique described 
earlier was used. t' 9 Although the one-patch technique 
gave acceptable results, we changed to the two-patch 
technique because we believed it produces less AV valve 
distortion. The avoidance of dividing the superior and 
inferior bridging leaflets was appealing because of the rare 
incidence Of dehiscence of the delicate leaflets from the 
VSD patch when they were divided. The pericardial ASD 
patch completely eliminated the occasional occurrence of 
postoperative hemolysis when a small jet through the left 
AV valve struck the Dacron ASD patch. The left AV valve 
cleft was Closed in 93.1% (189/203) but left alone when 
valve leaflet tissue was insufficient and closure of the cleft 
might cause significant stenosis. A more complex valvulo- 
ptasty (i.e., chordal shortening) or annuloplasty (or both) 
was require d in four patients. 
Intraoperative postrepair evaluation and monitoring. 
As the patient is being warmed and weaned from bypass, left 
atrial, pulmonary artery, and right atrial oximetric monitor- 
ing catheters are inserted for intraoperative postrepair and 
postoperative monitoring. Since August 1990, transesopha- 
geal echocardiography as been routinely used to further 
assess the Completeness of repair. On rare occasions, rein- 
stitution of bypass for further epair of the left or right AV 
valves or VSD was necessary if the echocardiogram showed 
more than mild regurgitation or more than a trivial shunt. 
The combination of invasive monitoring and transesopha- 
geal echocardiography allows us to better quantitate the 
findings oflechocardiography (Fig. 2). 
Intravenous nitroglycerin at a dosage of 0.5 to 10/xg/kg 
per minute is currently the most common drug given in the 
early postoperative period. It is administered via the right 
Table I. Cardiac anomalies associated with 
complete A V septal defects 
Anomalies No. of patients % 
ASD secundum 50 24.9 
PDA 48 23.6 
Multiple VSDs 7 3.4 
DORV 6 3.0 
TOF 3 1.5 
Left SVC 4 2.0 
Left-sided obstructive r gion 10 4.9 
Double-orifice l ft AV valve 6 3.0 
Single left-sided papillary muscle 3 1.5 
ASD, Atrial septal defect; PDA, patent ductus arteriosus; VSD, ventricular 
septal defect; DORV, double-outlet right ventricle; TOF, tetralogy of
Fallot; SVC, superior vena cava. 
atrial or pulmonary arterial line to attempt o keep the 
pulmonary artery pressure less than 40% of systemic pres- 
sure. If dopamine is required in a dosage of more than 5 
txg/kg per minute, it is delivered via the left atrial line in an 
attempt o reduce its potential pulmonary vasoconstrictive 
effects. Administration of chlorpromazine is begun in the 
immediate postoperative p riod in a dosage of 0.5 to 2.0 mg 
every 4 hours for its pulmonary vasodilatory (a-adrenergic 
blockade) and central nervous ystem sedative ffects. 
If pulmonary hypertension (>50% of systemic pres- 
sure) persists after chlorpromazine in a dosage of 2 mg 
every 4 hours is given, then prazosin hydrochloride (an- 
other a-adrenergic blocker) is given orally or by nasogas- 
tric tube in dosages beginning with 0.25 mg every 4 hours 
and increasing radually until an upper limit of 2 mg every 
4 hours is reached. If a patient requires chlorpromazine or
prazosin hydrochloride for control of pulmonary hyper- 
tension, then one or both are continued for 2 to 4 weeks 
orally after discharge and the dosage is gradually reduced. 
Most patients were given digoxin and furosemide in 
standard doses for the first 1 to 2 months after the 
operation. Invasive cardiac monitoring lines are left in 
place for 1 to 5 days depending on the degree of pulmo- 
nary vasoreactivity. Most patients were extubated on the 
first or second postoperative day. The average length of 
hospital stay since 1990 has been 9 days. 
Postoperative valuation. A complete set of postoper- 
ative physiologic data was available in 175 patients 
(81.3%), including rhythm, pacemaker requirement, ino- 
tropic requirement, systemic arterial and pulmonary arte- 
rial pressures, right and left atrial pressures, and right 
atrial and pulmonary arterial oxygen saturations. 
Evidence of significant postoperative left AV valve regur- 
gitation by echocardiography or catheterization was evalu- 
ated carefully (Fig. 2). Early (perioperative) death was 
defined as occurring within 30 days of the operation or 
before hospital discharge after repair. Failure of left AV 
valve repair was defined as residual severe regurgitation that 
necessitated reoperation. Reoperations were analyzed and 
cause of reoperation was categorized as residual intracardiac 
shunt, left AV valve dysfunction, rhythm disturbance, or 
other. Timing of reoperation after repair was recorded. 
Other postoperative complications including neurologic, re- 
spiratory, and infectious complications were also noted. 
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Fig. 1. A to E, Surgical technique of complete AV septal repair. See d tails in the text. 
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Fig° 2. Sequential assessment of left AV valve function before and after repair of complete AV septal 
defects. N/A, Not available. 
Postoperative patient status was determined by direct 
evaluation of the patient by the pediatric ardiologist and 
surgeon or by letters from referring physicians. If recent 
(<6 months) follow-up had not been accomplished, the 
patients were contacted irectly by telephone during the 
months of January, February, and March 1995. 
Statistical analysis. Data were entered into a comput- 
erized database and analyzed with Statistica software 
(Statsoft, Inc., Tulsa, Okla.). The cumulative survival 
estimates of patients were made by the actuarial (life- 
table) method and the 95% confidence intervals for the 
estimates were determined by the Greenwood formula. 8 
The trends in patient population and surgical technique in
each 5-year period were analyzed by analysis of variance. 
The multiple logistic regression model was used to 
identify the independent contribution of potential risk 
factors for patient mortality and failure of left AV valve 
repair in the total cohort of 203 patients. The variables 
entered into the risk factor analysis are summarized in 
Appendix 2. The selection of independent variables in the 
models was a forward stepwise method with a critical p 
value for variable inclusion and exclusion of 0.15. A p 
value of less than 0.05 was considered significant. 
Results 
Early and late mortality. There were 16 early 
deaths (7.9%). Operative mortality decreased signif- 
icantly over the period of the study from 19% (4/21) 
before 1980 to 3% (2/67) after 1990 (p = 0.03). 
Primary causes of early death are shown in Table II. 
Six patients were lost to follow-up. Follow-up in the 
remaining; 197 patients ranged from 2.2 months to 
233.9 months (19.5 years) with a median of 94.5 
months (7.1 years). Two patients died late, 4 and 8 
months after the operation, of sepsis and congestive 
heart failure. Overall survival, including early 
Table II. Primary cause of early death 
Causes No. of patients 
Pulmonary hypertensive crisis 6 
Acute ventricular failure 4 
Sepsis 2 
Arrhythmia 2 
Multisystem organ failure 2 
Total mortality 16 (7.9%) 
deaths, was 91.3% _+ 0.04% at 1 and 10 years after 
the operation (Fig, 3). 
Risk factors associated with early death are shown 
in Table III. By multivariate analysis, pulmonary 
hypertensive crisis, immediate severe postoperative 
left AV valve regurgitation, double-orifice l ft AV 
valve, and prematurity were the significant risk 
factors for early death. By multivariate analysis, 
neither preoperative puhnonary hypertension or 
preoperative severity of left AV valve regurgitation 
predicted early death. 
Survival in patients with moderate or severe left 
AV valve regurgitation immediately after the oper- 
ation was significantly less than survival of patients 
with trivial or mild left AV valve regurgitation at 1 
month and 1, 5, and 10 years after the operation. All 
deaths in patients with moderate or severe left AV 
valve regurgitation occurred within the first year 
after the operation. Survival at 1 month and 1, 5, and 
10 years after the operation of patients who had a 
postoperative pulmonary hypertensive crisis was 
also significantly less than that of patients without a 
pulmonary hypertensive crisis. Risk of mortality in 
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Fig. 3. Patient survival including early mortality. Vertical bars enclose a 95% confidence interval. 
Table III. Risk factors for early death 
Univariate Multivariate 
Factors (p value) (p value) 
Pulmonary hypertensive crisis <0.0001 <0.0001 
Severe left AV valve regurgitation <0.001 <0.001 
in the immediate postop, period 
Double-orifice left AV valve <0.0001 0.02 
Prematurity <0.001 0.02 
Left-sided obstructive l sion <0.001 NS 
Requirement of pacemaker <0.01 NS 
Preop. severe left AV valve 0.01 NS 
regurgitation 
NS, Not significant. 
Table IV. Major reoperation after repair of 
complete AV septal defects 
Reoperations No. of patients 
Left AV valve regurgitation 8 
Residuai VSD 3 
Permanent pacemaker implantation 5 
RVOT reconstruction 1 
Apicoaortic onduit 1 
Total reoperations 18 (8.9%J 
VSD, Ventricular septal defect; RVOT, right ventricular outflow tract. 
patients with a postoperative pulmonary hyperten- 
sive crisis was highest during the first 3 months after 
the operation. 
Preoperative and early and late postoperative 
evaluation of left AV valve. Left AV valve regurgi- 
tation was evaluated before the operation, during 
or immediately after the operation, at discharge, 
and late after repair of complete AV septal 
defects (see Fig. 2). Diagnostic technique in- 
cluded cineangiography (preoperative, late post- 
operative), transthoracic echocardiography (pre- 
operative, immediately after operation, at dis- 
charge, and at late follow-up) and transesophageal 
echocardiography (immediately after operation). 
Immediate postoperative evaluation included 
transthoracic echocardiography in the intensive 
care unit before July 1990 and intraoperative 
postrepair transesophageal echocardiography af- 
ter August 1990. Immediately after repair, 90% of 
patients had less than moderate regurgitation and 
9.5% of patients had moderate regurgitation. At 
the time of discharge, the results were further 
improved and 96% of 187 operative survivors had 
less than moderate regurgitation. At a median of 
59 months (range from 2.8 to 194.6 months) after 
the operation, results of late postoperative l ft 
AV valve function were available for 146 patients 
(71.9%). One hundred forty patients had trivial or 
mild left AV valve regurgitation, and six patients 
had moderate left AV valve regurgitation (see 
Fig. 2). None of these 146 patients had moderate 
or severe left AV valve stenosis. 
Reoperation. Seventeen patients underwent one 
reoperation or more performed over a range of 3 to 
72 days after the initial repair (Table IV). Three 
patients required reoperation for residual VSD and 
one of them required combined annuloplasty and a 
second VSD patch closure because of severe regur- 
gitation and residual intracardiac shunt. Five pa- 
tients required pacemaker implantation because of 
complete (n = 1) or second-degree h art block (n = 
2), postoperative sinus bradycardia (n = 1), and 
syncopal episodes (n = 1). Eight patients required 
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Table V. Reoperation because of left AV  valve regurgitation 
Initial operation Left AV  valve regurgitation 
Before Immediat@ 
Patient C/eft Annulo- Valvulo- Associated first after first Before 
(by year) closure plasty plasty anoma(y operation operation reopemtion 
type of 
reoperation 
Days Current left 
after first A V valve 
operation Survival regungitation 
2 + 
5 + + 
6 + 
Minimal left Severe Moderate Severe 
AV valve 
leaflet 
tissue 
Dehiscence Moderate Mild Severe 
of cleft 
- Minimal left Moderate Mild 
AV valve 
leaflet 
tissue 
- Double-orifice Moderate 
left AV 
valve, 
hypoplastic 
left ventricle 
- Dehiscence Severe Mild 
of deft 
suture 
- SBE, dens- Moderate Mild 
cence of 
deft of cleft 
- Asymmetric Moderate 
left AV 
valve 
- Double- Severe 
orifice left 
AV valve 
Severe 
Moderate Severe 
Mild 
Moderate 
Annuloplasty, 
redo VSD 
patch 
36 Y Mild 
Annuloplasty, 5 Y 
reapproxima- 
tion of the 
cleft 
Valvuloplasty, 18 N 
left AV valve 
replacement 
Annuloplasty 3 N 
Mild 
Severe Reapproxima- 62 Y Mild 
tion of the 
cleft 
Severe Closure of per- 72 Y Mild 
foration, reap- 
pro~nation 
of the cleft 
Moderate Annuloplasty 18 Y Mild 
Severe Left AV valve 8 N 
replacement 
SBE, Subacute bacterial endocarditis; VSD, ventricular septal defect. 
reoperations because of residual severe left AV 
valve regurgitation after the initial operation (Table 
V); five patients initially did not have cleft closure 
because of inadequate left AV valve tissue. Three 
patients had separation of initial cleft closure be- 
cause of subacute ndocarditis (n = 1) and unknown 
reasons (n = 2)i 
Factors associated with any reoperation and re- 
operation for left AV valve regurgitation were ana- 
lyzed by univariate and multivariate logistic regres- 
sion (Tables VI and VII). By multiple logistic 
regression, double-orifice left AV valve, preopera- 
tive and immediate postoperative severe AV valve 
regurgitation, significant step-up of oxygen satura- 
tion betwden the right atrium and pulmonary artery 
(pulmona~/systemic flow ratio >1.5), and pulmo- 
nary hypertensive crisis were the risk factors for 
overall repperation. Immediate postoperative se- 
vere left AV valve regurgitation and double-orifice 
Table VI. Risk factors for major reoperation 
Univariate Multivariate 
Factors (p value) (p value) 
Double-orifice left AV valve <0.0001 0.001 
Preop. severe left AV valve <0.001 0.001 
regurgitation 
Immediate postop, severe 0.001 0.001 
left AV valve regurgitation 
RA-PA oxygen step-up 0.005 0.003 
Pulmonary hypertensive crisis 0.006 0.003 
Total CPB time 0.02 NS 
RA, Right atrium; PA, pulmonary artery; CBP, cardiopulmonary b pass; 
NS, not significant. 
left AV valve predicted the requirement of reopera- 
tion for residual left AV valve regurgitation. 
Other trends over the past 20 years. The propor- 
tion of patients with palliative pulmonary artery 
band has decreased significantly from 76.2% before 
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Table VII. Risk factors for reoperation resulting 
from residual eft A V valve regurgitation 
Univariate Multivariate 
Factors (p value) (p value) 
Double-orifice left AV valve <0.001 <0.001 
immediate postop, severe left <0.001 <0.001 
AV valve regurgitation 
Preop, severe left AV valve <0.001 NS 
regurgitation 
Postop. bleeding 0.03 NS 
NS, Not significant. 
1979 to 28.4% after 1990 (p < 0.001 by analysis of 
variance ) .Before 1979 more than 80% of the repairs 
were performed with a classic single patch technique 
but 97% of repairs were performed with the two- 
patch technique after 1990 (p < 0.001 by analysis of 
variance). The proportion of patients with postop- 
erative pulmonary hypertensive crises has decreased 
substantially (Table VIII). 
Discussion 
Since the first successful repair of complete AV 
septal defects by Lillehei in 1954, I° operative mor- 
tality has declined from almost 50% in early reports 
to 3% to 6% recently. 2'5' 11 In our institution, the 
operative mortality of complete AV septal defects 
has also significantly decreased from 19% before 
1980 to 3% after 1990 with an overall mortality rate 
of 7.9%. The improvement in surgical results 
in recent years is likely related to a greater under- 
standing of the structure of this lesion, improved 
perfusion methods, improved myocardial protec- 
tion, improved intraoperative transesophageal cho- 
cardiographic assessment, and improved postoperative 
management. However, despite these improvements 
in early mortality, failure of achieving acompetent left 
AV valve remains the most significant cause of early 
and late deaths and need for reoperation)' 4,12 
The choice of one-patch versus two-patch repair 
and effect of cleft closure have been controversial. 
In our institution, the single patch technique was 
used through 1986, and we converted to a two-patch 
technique after 1987 (Table VIII). Both techniques 
provided good early and late results, and no statis- 
tically significant difference was observed in early 
and late mortality or need for reoperation between 
the two groups. However, our current preference is
the two-patch technique because we believe avoid- 
ing division of the bridging leaflet with type C 
defects, which is always necessary in the single patch 
technique, can be avoided. 13 Excellent visualization 
of the common AV valve apparatus i  possible by 
both techniques, t2 
Although repair techniques of AV septal defects 
have evolved over the past 20 years, the cleft of left 
AV valve has been routinely closed in 93% (189/ 
203) of patients except when valve leaflet issue was 
inadequate or cleft closure might cause significant 
stenosis. With this consistent approach for 20 years, 
left AV valve regurgitation was trivial or mild in 
93% of patients examined (a mean of 59 months 
after repair) in most recent evaluation using angiog- 
raphy or echocardiography. More importantly, none 
of these patients had moderate or severe left AV 
valve stenosis and only two patients had mild left 
AV valve stenosis. Subsequently the 10-year actuar- 
ial survival is 91.3% _+ 0.04% and all of the long- 
term survivors are in New York Heart Association 
class I or II. 
Our unique experience with consistent cleft clo- 
sure over the past 20 years also gives us an oppor- 
tunity to assess the effect of repair by means of cleft 
closure on patients with substantial preoperative 
AV valve regurgitation. The majority of patients 
with moderate or severe regurgitation before the 
operation had improved left AV valve function in 
the immediate postoperative period. Further im- 
provement was observed at the time of discharge 
(see Fig. 2). Five percent o 10% of patients had no 
improvement in severity of left AV valve regurgita- 
tion after the operation, but none had progression 
(Appendix III). 
Technical failure of the repair, including separa- 
tion of previously sutured clefts or incomplete ap- 
position of the valve leaflets, was detected in all of 
the patients requiring reoperation for left AV valve 
regurgitation. Reoperation for left AV valve regur- 
gitation consisted of a second closure of the cleft or 
annuloplasty (or both), usually resulting in an excel- 
lent outCome. Only two patients eventually required 
valve replacement in our series and both died. 
By multiple regression analysis, severe left AV 
valve regurgitation atimmediate postoperative eval- 
uation was recognized as a risk factor for early death 
and need for reoperation. The effect of annuloplasty 
in this difficult group of patients would be interest- 
ing. Annuloplasty was usually reserved for reopera- 
tion and only four patients had De Vega type 
annuloplasty or an annuloplasty as described by 
Capuoya, Laks and associates 6 at the initial opera- 
tion. This technique by Laks includes annuloplasty 
at the lateral commissures with multiple pericardial 
pledgets. The group from the University of Califor- 
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TabLe VIII. Trends in patient distribution and surgical techniques between 1974 and 1995 
1974-1979 1980-1984 1985-1989 1990-1995 
% No. % No. % No. % No. p Value 
Infants (<-1 yr) 1.0 2 19.0 
Postop. PH crisis 19.0 4 7.1 
PA banding 76.2 16 73.8 
Two-patch technique 19.0 4 35.7 
8 45.2 33 73.1 49 <0.001 
3 9.6 7 7.5 5 NS 
31 35.6 26 28.4 19 <0.001 
15 42.5 31 97.0 65 <0.001 
PH, Pulmonary hypertension; PA,pulmonary artery; NS, not significant. 
nia at Los Angeles used this technique on 63 of 105 
patients (60%) at initial repair with good results. 6
Although annuloplasty at at initial attempt of repair 
may further improve the postoperative left AV valve 
function, this might also produce early or late left 
AV valve stenosis. Because no moderate or severe 
left AV valve stenosis occurred with our approach, 
we continue to use annuloplasty in highly selected 
patients. 
Double-orifice left AV valve remains a significant 
cause of early mortality and need for reoperation i  
our series as with the larger experience from Boston. 3
This rare but difficult condition was encountered in six 
patients (3,0%) in our series and two patients required 
reoperation and subsequently died. These two patients 
had no cleft closure and massive left AV valve regur- 
gitation resulted. The other four patients had partial 
cleft closure in which a technique similar to that 
described by Lee and associates 14from the Mayo 
Clinic was used. One patient died of acute ventricular 
failure. The remaining three patients did not require 
reoperation although mild to moderate l ft AV valve 
regurgitation persisted. 
Although risk factor analysis did not demonstrate a 
statistically significant advantage of cleft closure in 
reducing the need for reoperation, this was not sur- 
prising because the majority of patients (93%) had 
cleft closure whenever feasible. Because the common 
cause of reoperation i a series of trileaflet repairs was 
related to the fact that the cleft was not closed during 
the initial operation, 2' 15 management of the valve as a 
bileaflet structure has resulted in a low likelihood of 
reoperation for failure of left AV valve repair. 
Pulmonary hypertensive crisis is the most fre- 
quent cause of early death (see Table II) and a 
highly significant risk factor for early deaths (see 
Table III); as well as need for major reoperation, 
according to multiple regression analysis (see Table 
VI). With improved postoperative management in- 
cluding prophylactic administration of nitroglycerin, 
nitroprusside, chlorpromazine, or prazosin hydro- 
chloride, or a combination of these drugs, the 
incidence of this potentially fatal complication has 
been decreased from 19% (1975 to 1979) to 7.5% 
(1990 to 1995) (see Table VIII). Early definitive 
repair before significant pulmonary vascular disease 
develops has also contributed to this improvement. 
Nonetheless, risk factor analysis for pulmonary hy- 
pertensive crisis is warranted because the only two 
early deaths ince 1990 were related to this compli- 
cation. Inhalation of nitric oxide may be beneficial in 
treating such patients. 
Pulmonary artery banding did not predict either 
mortality or need for reoperation, probably because 
patients who died after pulmonary artery banding or 
who had definitive repair in another institution were 
not included in this study (Appendix I). Currently 
we prefer to perform complete repair in infancy 
before significant pulmonary vascular disease or 
congestive heart failure develops (see Table VIII). 16 
Pulmonary artery banding is considered for patients 
with multiple VSDs, severely imbalanced ventricles, 
prematurity, or other associated anomalies. 
In summary, complete AV septal defects can be 
repaired in infancy with low mortality and good 
midterm to long-term outcome. Routine approxima- 
tion of the cleft is safe and the likelihood of reop- 
eration for left AV valve regurgitation is low. Most 
long-term survivors have mild or trivial left AV valve 
regurgitation at most recent follow-up and all are in 
New York Heart Association class I or II. No 
deterioration in left AV valve function has been 
observed in any long-term survivors during a mean 
follow-up of 94 months. 
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Discuss ion 
Dr. Gordon K. Danielson (Rochester, Minn.). The au- 
thors are to be congratulated on their excellent early and 
late results of repair of complete AV septal defect, or 
complete AV canal, as I was trained to call it. We agree 
with their assessment that creation of a competent left AV 
valve, alias mitral valve, it the cornerstone of surgical 
repair. The authors have discussed the relative merits of 
the two highly effective basic types of repair, the so-called 
classic one-patch repair, introduced by Drs. Kirklin and 
Rastelli, and the two-patch repair, which was actually 
performed earlier by Dr. Lillehei in Minneapolis. 
We also agree with the authors that the closure line or 
cleft of the anterior and posterior portions of the new 
anterior (septal) leaflet of the mitral valve is a weak point 
in the repair. Because we have also seen persistent or 
recurrent valve insufficiency in our patients and those of 
others when cleft closure was not done, we also favor at 
least a partial closure of the cleft. 
[Slide] This slide shows freedom from reoperation for 
mitral insufficiency in our series stratified according to 
degree of residual postrepair mitral insufficiency as assessed 
by intraoperative double-sampling dye curves. Reoperation 
was much more likely in patients with moderate or severe 
insufficiency than in those with mild or no insufficiency. 
These data emphasize the importance of assessing the mitral 
valve intraoperatively with echocardiography and, if avail- 
able, dye curves. We have found that dye curves better 
quantify the valve insufficiency and echocardiography pro- 
vides better localization and characterization f the insuffi- 
ciency. 
The authors report no late progression of mitral insuf- 
ficiency in their patients. This is at variance with our 
experience, in which a slow but progressive decline in 
freedom from reoperation for mitral insufficiency oc- 
curred over time. However, this averaged less than 1% per 
year over a 20-year interval. 
I was impressed that valve repair could be performed 
instead of valve replacement in six of the eight patients 
who required reoperation for severe valve insufficiency. 
This would imply that the repair had broken down or that 
it had not been adequate in the first place, rather than that 
there had been inadequate tissue for repair or the valve 
had a nonreconstructible lesion, such as double-orifice 
mitral valve. Put another way, I would like to ask the 
question: "Do only 1% of patients with complete AV 
canal have nonrepairable valves?" 
Dr. Bando. Thank you for your kind comments, 
Dr. Danielson. Regarding the question as to why only two 
patients (1%) required mitral valve replacement, our 
patient population was somewhat skewed because pa- 
tients who had pulmonary artery banding and died before 
definitive repair were not included in this analysis. Thus 
patients who might otherwise have required mitral valve 
replacement may not have come to definitive repair. 
Regarding the eight patients who required reoperation, 
three patients had dehiscence of the cleft closure and 
these patients had reapproximation of the cleft. Among 
two patients with double-orifice l ft AV valve, one had a 
De Vega annuloplasty and one had mitral valve replace- 
ment. Two other patients had annuloplasty for inadequate 
valve tissue and one patient eventually had mitral valve 
replacement after failure of annuloplasty. It is our policy 
to use annuloplasty inhighly selected patients at the initial 
attempt because this might produce arly and late left AV 
valve stenosis. Because no moderate or severe left AV 
valve stenosis has been observed uring the past 20 years, 
we continue to use this approach. 
Dr. Frank L. Hanley (San Francisco, Calif.). It is generally 
agreed that the management of the left AV valve is the most 
critical part of the repair of this lesion; however, exactly how 
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to manage the left AV valve remains a subject of contro- 
versy. Attention has centered around the trileaflet versus the 
bileaflet reconstruction. Clearly, competent valves can be 
achieved with the use of either technique, and, similarly, 
each technique can result in failure. It seems that the 
controversy distills down to the following issue. 
The trileaflet valve is attractive because it preserves the 
leaflet tissue of the AV valve in this lesion in a natural 
configuration. The concern is that many who have used 
this technique, at least in young infants, have found that 
the results can be unpredictable, ven in valves that were 
completely competent before the operation. The bileaflet 
repair, on the other hand, seems to provide more predict- 
able early results; however, the nagging concern is that 
with leaflet scarring at the cleft closure site, long-term 
difficulties with either stenosis or distortion and late 
insufficiency potentially could be a problem. 
The most important contribution of this study is that it 
provides long-term follow-up exclusively with the cleft 
closure technique. The results how that this type of repair 
holds up over time without stenosis and without degener- 
ation of the valve. There are 63 patients with more than 10 
years of follow-up with no trend toward valve degenera- 
tion. This information eliminates one of the major con- 
cerns with using the bileaflet approach. 
I have three questions for the authors. In your series, 
three valves that failed showed evidence of dehiscence. 
Do you consider dehiscence to be a primary problem or a 
secondary problem resulting from poor alignment of 
leaflet tissue and subsequent tension? 
The second question relates to pulmonary hypertension. 
You indicate that pulmonary hypertension seemed to de- 
crease over time in your series. You also have shown that age 
at repair has decreased over time. Have you analyzed these 
two variables to determine if the decrease in pulmonary 
hypertension is linked to earlier age at repair? 
Finally, you mentioned that since 1990 you have used 
primary repair rather than banding. During this time, 28% 
of patients had pulmonary artery banding. Can you iden- 
tify the criteria you use presently to decide when you band 
and when you do not band? 
Dr. Bando. I appreciate your comments, Dr. Hanley. 
Let me answer your last question first. The indications for 
the pulmonary artery band in the current era at our 
institution !s multiple VSDs, significant imbalance that 
excludes a two-ventricle repair, or concomitant noncar- 
diac disease such as sepsis or prematurity. 
Your second question is related to the incidence of 
postoperative pulmonary hypertensive crisis. Early defin- 
itive complete repair and improvements in postoperative 
management have a major impact on the incidence of 
pulmonary hypertension crisis. We routinely use prophy- 
lactic chlorpromazine or prazosin hydrochloride, or both. 
Your first question is related to the incidence of dehis- 
cence and the repair technique of the left AV valve. All 
the dehiscences in our experience occurred within the first 
80 days after the operation. Repair of the left AV valve 
with minimal valve tissue remains a challenge. Our cur- 
rent policy is to close the "cleft" if there is enough tissue 
and add a De Vega annuloplasty if necessary. However, 
we accept moderate regurgitation rather than creating 
significant left AV valve stenosis. 
Dr. Hanley. I would like to make a final comment 
regarding pulmonary hypertension. Your specific pharmaco- 
logic management plan may be affecting the incidence of 
pulmonary hypertension; however, early repair itself pre- 
vents disease in the pulmonary vasculature. This factor may 
be responsible for the reduction i  pulmonary hypertension. 
Dr. Bando. We did not specifically evaluate the impact 
of the timing of repair on the incidence of postoperative 
pulmonary hypertensive crisis. However, we currently 
operate on younger patients, even before 3 months old, 
and this has had some impact inasmuch as significant 
pulmonary vascular disease may be uncommon in this 
group of patients. 
Dr. Giovanni Stellin (Padova, Italy). Similar data from 
our institution, the University of Padova, have been 
presented at the meeting of the Castaneda Society. Over 
a period of 10 years, we have operated on 200 patients for 
AV septal defect. According to our statistical analysis, 
residual eft AV valve regurgitation is correlated with the 
presence of preoperative AV valve incompetence. Fur- 
thermore, the presence of left AV valve regurgitation is
much lower in patients operated on before the age of 4 
months. For this reason we now electively repair AV 
septal defect soon after the neonatal period at about the 
age of 1 or 2 months, just to avoid the onset of preoper- 
ative AV valve regurgitation. What is your experience in 
this matter and what is your ideal age at which to correct 
a complete form of AV septal defect? 
Dr. Bando. According to our data, if preoperative AV 
valve regurgitation is divided into four different categories 
(none or trivial, mild, moderate, and severe), there was no 
significant correlation between severity of preoperative 
and postoperative r gurgitation. However, if we catego- 
rize severe versus less than moderate, here is a significant 
correlation, as you mentioned. Recently we have pre- 
ferred to perform definitive repair at 3 to 6 months of age, 
before severe AV valve regurgitation or irreversible pul- 
monary vascular disease develops. 
Dr. Joseph J. Amato (New Hyde Park, N.Y.). I would 
like you to correlate two facts that you brought up. You 
stated that you closed 93% of the clefts, and you stated 
that three patients had single papillary muscles. We do not 
close the cleft on valves with single papillary muscles. I 
was wondering what the rate of incompetence was in those 
patients. Did you close the cleft, did you leave it open, and 
if you left it open, what was the percent of incompetence? 
Dr. Bando. Among the three patients with single pap- 
illary muscle, one patient died of severe left AV valve 
regurgitation despite annuloplasty. Two patients are still 
surviving with mild to moderate left AV valve regurgita- 
tion. We also do not close the cleft among these patients. 
Dr. Edward L. Bove (Ann Arbor, Mich.). May I ask one 
other point of clarification, specifically regarding the 
patients in the pulmonary artery banding group? Did any 
patients undergo banding and not come to repair because 
they died before repair or because they had inoperable 
defects, particularly some of the patients who might have 
had significant AV valve regurgitation? 
Dr. Bando. Patients who had pulmonary artery banding 
and died before definitive repair or patients who had 
pulmonary artery banding and had definitive repair else- 
where were not included in this study. 
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Appendix I. Patients with pulmonary artery banding without definitive repair 
Patients 1974-1979 1980-1984 1985-1989 1990-1995 
Died before definitive repair 3 2 8 1 
Definitive repair elsewhere 2 4 4 4 
Waiting for definitive repair 0 0 0 4 
Total 5 6 12 9 
Appendix II. Potential risk factors for mortality and 
need for reoperation 
A. Preoperative risk factors 
Demographic variables 
Age at repair 
Gender 
Year of operation 
Weight at repair 
Down's syndrome 
Prematurity 
Morphologic variables 
Rastelli type structure 
Double-orifice l ft AV value 
Single left-sided papillary muscle 
Left-sided obstructive l sions 
Atrial septal defect (secundum) 
Patent ductus arteriosus 
Multiple VSDs 
Pulmonary artery banding 
Pulmonary hypertension 
Other cardiac lesions 
B. Intraoperative risk factors 
Single/double patch 
Cleft closure of left AV valve 
Annuloplasty of left AV valve 
Valvuloplasty 
Intraoperative or immediate postoperative l ft AV valve 
regurgitation 
Total cardiopulmonary b pass 
Circulatory arrest ime 
Aortic crossclamp time 
C. Postoperative risk factors 
Postoperative (at discharge and long-term follow-up) left AV 
valve regurgitation 
Pulmonary arterial pressure 
Pulmonary hypertensive crisis 
Systemic pressure 
Right atrial and pulmonary artery saturation step-up 
Postoperative bleeding 
Postoperative pacing 
Absence of sinus rhythm 
Infectious complications 
Neurologic omplications 
Other complications 
Appendix III. Change of left AV valve function 
before and after repair of complete AV septal defects 
Preop. A V Immediate Before Late 
valve regurgitation Change postop, discharge follow-up 
Severe Severe 1 0 0 
(n = 18) Moderate 11 4 1 
Mild 6 8 6 
Tivial 0 3 4 
Death - -  3 4 
NA - -  - -  3 
Moderate Severe 0 0 0 
(n = 82) Moderate 8 2 4 
Mild 65 36 11 
Trivial 8 34 42 
Death 1 10 11 
NA - -  - -  14 
Mild Severe 0 0 0 
(n = 76) Moderate 0 0 0 
Mild 24 15 12 
Trivial 52 58 48 
Death - -  3 3 
NA - -  - -  13 
None Severe 0 0 0 
(n - 27) Moderate 0 0 0 
Mild 0 0 0 
Trivial 27 27 18 
Death - -  - -  - -  
NA - -  - -  9 
